Homestead Advisers Corp Trims Position in Integer Holdings Corporation (NYSE:ITGR)

Homestead Advisers Corp reduced its stake in shares of Integer Holdings Corporation (NYSE:ITGR - Free Report) by 32.5% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 40,670 shares of the medical equipment provider's stock after selling 19,600 shares during the period. Homestead Advisers Corp owned 0.12% of Integer worth $4,799,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. TD Private Client Wealth LLC boosted its holdings in shares of Integer by 5.8% during the 1st quarter. TD Private Client Wealth LLC now owns 1,524 shares of the medical equipment provider's stock worth $180,000 after purchasing an additional 83 shares during the last quarter. HighPoint Advisor Group LLC raised its position in shares of Integer by 6.4% during the 4th quarter. HighPoint Advisor Group LLC now owns 1,684 shares of the medical equipment provider's stock valued at $234,000 after buying an additional 101 shares during the period. Corient Private Wealth LLC raised its position in shares of Integer by 6.4% during the 4th quarter. Corient Private Wealth LLC now owns 1,969 shares of the medical equipment provider's stock valued at $261,000 after buying an additional 118 shares during the period. Xponance Inc. raised its position in shares of Integer by 5.1% during the 1st quarter. Xponance Inc. now owns 2,518 shares of the medical equipment provider's stock valued at $297,000 after buying an additional 122 shares during the period. Finally, Bessemer Group Inc. raised its position in shares of Integer by 73.1% during the 1st quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock valued at $35,000 after buying an additional 125 shares during the period. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Stock Down 0.5%

Shares of NYSE:ITGR traded down $0.52 during trading on Friday, hitting $106.58. The company's stock had a trading volume of 169,674 shares, compared to its average volume of 494,350. The business has a 50 day moving average price of $119.04 and a two-hundred day moving average price of $123.88. The company has a market capitalization of $3.72 billion, a PE ratio of 50.51, a P/E/G ratio of 1.00 and a beta of 0.98. The company has a debt-to-equity ratio of 0.78, a quick ratio of 2.14 and a current ratio of 3.40. Integer Holdings Corporation has a fifty-two week low of $104.93 and a fifty-two week high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings results on Thursday, July 24th. The medical equipment provider reported $1.55 EPS for the quarter, missing the consensus estimate of $1.57 by ($0.02). The business had revenue of $476.00 million during the quarter, compared to analyst estimates of $464.37 million. Integer had a return on equity of 11.95% and a net margin of 4.38%. The business's revenue was up 11.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.30 EPS. As a group, research analysts expect that Integer Holdings Corporation will post 6.01 EPS for the current fiscal year.

Insider Activity at Integer

In related news, Director Martin C. Maxwell sold 8,720 shares of the stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $120.56, for a total value of $1,051,283.20. Following the transaction, the director owned 22,170 shares of the company's stock, valued at $2,672,815.20. This represents a 28.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Donald J. Spence sold 14,739 shares of the company's stock in a transaction on Wednesday, June 4th. The shares were sold at an average price of $120.38, for a total transaction of $1,774,280.82. Following the completion of the transaction, the director owned 18,781 shares of the company's stock, valued at $2,260,856.78. This represents a 43.97% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 362,434 shares of company stock valued at $44,577,115 over the last quarter. 2.16% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. Wells Fargo & Company reduced their price target on shares of Integer from $152.00 to $132.00 and set an "overweight" rating on the stock in a research report on Friday. Raymond James Financial reduced their price target on shares of Integer from $150.00 to $143.00 and set an "outperform" rating on the stock in a research report on Friday. Truist Financial reduced their price target on shares of Integer from $145.00 to $137.00 and set a "buy" rating on the stock in a research report on Friday. Wall Street Zen raised shares of Integer from a "sell" rating to a "hold" rating in a research report on Monday, May 19th. Finally, Citigroup raised shares of Integer from a "hold" rating to a "strong-buy" rating and lifted their price target for the company from $133.00 to $140.00 in a research report on Thursday, May 22nd. Two equities research analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, Integer has an average rating of "Moderate Buy" and an average price target of $140.25.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.